Clinical Trial Update: Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of pevifoscorvir sodium (ALG-000184) in adults with moderate hepatic impairment and in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• Pevifoscorvir Sodium (Pevifoscorvir sodium)

Snippet

Sponsor: Aligos Therapeutics | Conditions: Chronic Hepaititis B Infections | Phase 1 | Status: RECRUITING